Ravi Misra
Stock Analyst at Truist Securities
(0.68)
# 4,108
Out of 5,120 analysts
10
Total ratings
50%
Success rate
-11.87%
Average return
Main Sectors:
Stocks Rated by Ravi Misra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Hold | $120 → $135 | $103.36 | +30.61% | 2 | Dec 18, 2025 | |
| IART Integra LifeSciences Holdings | Reiterates: Hold | $15 → $13 | $11.16 | +16.49% | 1 | Nov 3, 2025 | |
| TDOC Teladoc Health | Downgrades: Hold | $42 → $35 | $5.37 | +551.77% | 2 | Aug 2, 2022 | |
| ALGN Align Technology | Upgrades: Buy | $683 | $163.63 | +317.41% | 3 | Apr 22, 2021 | |
| NNOX Nano-X Imaging | Initiates: Buy | $65 | $2.72 | +2,289.71% | 1 | Sep 15, 2020 | |
| GKOS Glaukos | Upgrades: Buy | $65 | $117.47 | -44.67% | 1 | Jan 6, 2020 |
Teleflex
Dec 18, 2025
Maintains: Hold
Price Target: $120 → $135
Current: $103.36
Upside: +30.61%
Integra LifeSciences Holdings
Nov 3, 2025
Reiterates: Hold
Price Target: $15 → $13
Current: $11.16
Upside: +16.49%
Teladoc Health
Aug 2, 2022
Downgrades: Hold
Price Target: $42 → $35
Current: $5.37
Upside: +551.77%
Align Technology
Apr 22, 2021
Upgrades: Buy
Price Target: $683
Current: $163.63
Upside: +317.41%
Nano-X Imaging
Sep 15, 2020
Initiates: Buy
Price Target: $65
Current: $2.72
Upside: +2,289.71%
Glaukos
Jan 6, 2020
Upgrades: Buy
Price Target: $65
Current: $117.47
Upside: -44.67%